Tilray Inc (NASDAQ:TLRY) Shares Sold by Raymond James Financial Services Advisors Inc.

Raymond James Financial Services Advisors Inc. reduced its holdings in Tilray Inc (NASDAQ:TLRY) by 9.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 132,670 shares of the company’s stock after selling 14,029 shares during the period. Raymond James Financial Services Advisors Inc.’s holdings in Tilray were worth $305,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of TLRY. Clear Street Markets LLC acquired a new stake in Tilray in the third quarter valued at approximately $25,000. Lake Street Financial LLC acquired a new stake in Tilray in the third quarter valued at approximately $28,000. Great Valley Advisor Group Inc. acquired a new stake in Tilray in the third quarter valued at approximately $29,000. Stratos Wealth Advisors LLC acquired a new stake in shares of Tilray in the third quarter worth approximately $31,000. Finally, Simplicity Solutions LLC acquired a new stake in shares of Tilray in the third quarter worth approximately $32,000. 9.35% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on the company. CIBC lowered their price target on Tilray from $2.25 to $2.00 and set a “neutral” rating on the stock in a research note on Wednesday, April 10th. Alliance Global Partners lifted their price target on Tilray from $2.25 to $2.75 and gave the stock a “neutral” rating in a research note on Friday, April 5th. Finally, Canaccord Genuity Group lowered their price target on Tilray from $4.25 to $4.00 and set a “buy” rating on the stock in a research note on Wednesday, April 10th.

Tilray Stock Performance

NASDAQ TLRY opened at $1.72 on Tuesday. The stock’s fifty day moving average is $1.95 and its two-hundred day moving average is $1.95. The firm has a market capitalization of $1.33 billion, a P/E ratio of -3.91 and a beta of 2.36. The company has a debt-to-equity ratio of 0.11, a quick ratio of 1.18 and a current ratio of 1.92. Tilray Inc has a fifty-two week low of $1.50 and a fifty-two week high of $3.40.

Tilray Company Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.